October 3, 2022
Health Minister Katsunobu Kato The Pharmaceuticals and Medical Devices Agency (PMDA) will “appropriately review” Eisai’s Alzheimer’s drug lecanemab if it is officially filed for approval, Health Minister Katsunobu Kato said on September 30, two days after the company announced favorable...read more